Monoclonal gammopathy is present in one fourth of patients undergoing renal biopsy but is pathogenic only in half of them
In our cohort, one fourth of patients undergoing a renal biopsy had a monoclonal gammopathy, although in half of them the monoclonal gammopathy did not have a causative role in the kidney disease. Hence, it is impossible to conclude that a monoclonal gammopathy in the context of renal disease equates to a causal association without performing a renal biopsy because of the high frequency of monoclonal gammopathy in patients undergoing a kidney biopsy.
Authors
- Lorenzo Aterini (ORCID: https://orcid.org/0000-0002-0924-3450)
- Leonardo Caroti
- Marco Allinovi (ORCID: https://orcid.org/0000-0001-9949-3543)
- Calogero Lino Cirami (ORCID: https://orcid.org/0000-0002-3776-4691)
- Giulia Antognoli (ORCID: https://orcid.org/0000-0002-9676-7024)
Institutions
- European Society for Sexual Medicine (IT)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- University of Florence (IT)
Publication Details
- Journal
- Journal of Nephrology
- Published
- 2024-12-17
- DOI
- https://doi.org/10.1007/s40620-024-02160-x
- Citations
- 2
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.47